PL2114367T3 - Formulacje olopatadyny do miejscowego podawania donosowo - Google Patents

Formulacje olopatadyny do miejscowego podawania donosowo

Info

Publication number
PL2114367T3
PL2114367T3 PL07750153T PL07750153T PL2114367T3 PL 2114367 T3 PL2114367 T3 PL 2114367T3 PL 07750153 T PL07750153 T PL 07750153T PL 07750153 T PL07750153 T PL 07750153T PL 2114367 T3 PL2114367 T3 PL 2114367T3
Authority
PL
Poland
Prior art keywords
nasal administration
topical nasal
olopatadine formulations
olopatadine
formulations
Prior art date
Application number
PL07750153T
Other languages
English (en)
Inventor
Onkar N Singh
G Michael Wall
Rajni Jani
Masood A Chowhan
Wesley Wehsin Han
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2114367T3 publication Critical patent/PL2114367T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PL07750153T 2007-02-07 2007-02-07 Formulacje olopatadyny do miejscowego podawania donosowo PL2114367T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2007/003285 WO2008097220A1 (en) 2007-02-07 2007-02-07 Olopatadine formulations for topical nasal administration
EP07750153.4A EP2114367B1 (en) 2007-02-07 2007-02-07 Olopatadine formulations for topical nasal administration

Publications (1)

Publication Number Publication Date
PL2114367T3 true PL2114367T3 (pl) 2016-03-31

Family

ID=38542957

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07750153T PL2114367T3 (pl) 2007-02-07 2007-02-07 Formulacje olopatadyny do miejscowego podawania donosowo

Country Status (16)

Country Link
EP (2) EP2977042B1 (pl)
JP (1) JP5149308B2 (pl)
KR (1) KR20100014858A (pl)
CN (1) CN101621989A (pl)
AU (1) AU2007346121B2 (pl)
BR (1) BRPI0721255B8 (pl)
CA (1) CA2677631C (pl)
DK (1) DK2114367T3 (pl)
ES (2) ES2557939T3 (pl)
HK (1) HK1217090A1 (pl)
HU (1) HUE026162T2 (pl)
MX (1) MX2009008548A (pl)
PL (1) PL2114367T3 (pl)
PT (1) PT2114367E (pl)
SI (1) SI2114367T1 (pl)
WO (1) WO2008097220A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
CA2768006A1 (en) * 2009-07-17 2011-01-20 Alcon Research, Ltd. Olopatadine nasal spray regimen for children
KR101271925B1 (ko) * 2011-02-10 2013-06-05 비. 김 로버트 미네랄 알칼리수
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
CN103830219A (zh) * 2012-11-20 2014-06-04 深圳大佛药业有限公司 一种稳定的奥洛他定组合物
CN114980881A (zh) * 2019-12-06 2022-08-30 东兴药品工业株式会社 包含奥洛他定的鼻用组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JP3662944B2 (ja) * 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
EP1250133B1 (en) * 2000-01-25 2005-03-30 Alcon Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
JP2006508138A (ja) * 2002-11-12 2006-03-09 アルコン，インコーポレイテッド アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用
PL1814538T3 (pl) 2004-11-24 2010-02-26 Alcon Inc Sposób dostarczania donosowego sprayu

Also Published As

Publication number Publication date
MX2009008548A (es) 2009-08-18
BRPI0721255A2 (pt) 2013-01-01
HUE026162T2 (en) 2016-05-30
KR20100014858A (ko) 2010-02-11
EP2114367A1 (en) 2009-11-11
BRPI0721255B1 (pt) 2019-08-27
EP2114367B1 (en) 2015-11-04
SI2114367T1 (sl) 2016-01-29
ES2557939T3 (es) 2016-01-29
AU2007346121A1 (en) 2008-08-14
CA2677631A1 (en) 2008-08-14
DK2114367T3 (en) 2015-12-07
CA2677631C (en) 2014-05-13
PT2114367E (pt) 2016-02-01
JP5149308B2 (ja) 2013-02-20
JP2010518075A (ja) 2010-05-27
HK1217090A1 (zh) 2016-12-23
CN101621989A (zh) 2010-01-06
WO2008097220A1 (en) 2008-08-14
AU2007346121B2 (en) 2012-08-23
EP2977042A1 (en) 2016-01-27
BRPI0721255B8 (pt) 2021-05-25
EP2977042B1 (en) 2020-01-01
ES2781090T3 (es) 2020-08-28

Similar Documents

Publication Publication Date Title
GB0706744D0 (en) Nasal administration
ZA201400071B (en) Topical formulations having enhanced bioavailability
TWI367110B (en) Topical pharmaceutical formulation
IL192565A0 (en) Medicament for topical use
HK1217090A1 (zh) 用於局部鼻施用的奧洛他定製劑
ZA201101523B (en) Linaclotide-containing formulations for oral administration
BRPI0808293A2 (pt) "composições para administração nasal"
HK1145467A1 (en) Nasal delivery devices
PT2066179T (pt) Formulações para administração tópica local contendo indoxacarb
PL2120822T3 (pl) System irygacji nosa
GB0709513D0 (en) Topical formulations
EP2152274A4 (en) NASAL ADMINISTRATION OF BENZODIAZEPINES
EP2226071A4 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
ZA201003227B (en) Novel neurturin conjugates for pharmaceutical use
EP2206519A4 (en) MEDICINAL PREPARATION FOR ORAL ADMINISTRATION
GB0606415D0 (en) Topical drug delivery
IL198160A0 (en) Pharmaceutical formulations
EP2310022A4 (en) TOPIC MEDICINE
GB2471973B (en) Nasal delivery devices
BRPI0906045A2 (pt) "composição farmacêutica para administração nasal"
GB0612556D0 (en) Topical pharmaceutical formulations
ZA200905168B (en) Olopatadine formulations for topical nasal administration
EP2175918A4 (en) MANUFACTURE OF COMPONENTS OF MEDICAL DISTRIBUTORS
AU2007905789A0 (en) Nasal vaporiser device
GB0713093D0 (en) Pharmaceutical formulations